Buy Like Buffett
Watchlist

Flagship explainer

What drives Arcadia Biosciences, Inc.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity−45%Tax burden100%net income ÷ pretax incomeInterest burden93%pretax ÷ operating incomeOperating margin−51%operating income ÷ revenueAsset turnover0.48×revenue ÷ average assetsEquity multiplier1.94×average assets ÷ average equityAs of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$2.3MFY2025
Income before tax−$2.3MFY2025
Operating income−$2.5MFY2025
$4.9MFY2025
Ending assets$6.5MFY2025
Beginning assets$13.5MFY2024
$4.1MFY2025
$6.2MFY2024
Source:
  • SEC filingFiling detailsAccession 0000950170-25-044487
  • SEC filingFiling detailsAccession 0001193125-26-126238
· event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full Arcadia Biosciences, Inc. analysis at Buy Like Buffett